Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma R&D Productivity And Growth 2016: Innovation Performance Improves

Dec 15 2016

• By Markus Thunecke and Graham Scholefield

IV1611_Catenion_Wordcloud_1200

Related Content

External R&D Is Up, But Which Companies Are Reaping The Most Benefit?

Oct 05 2016

Value-Based R&D Pharma Productivity 2015: Oncology And Hep C Drive Top Performers

Dec 18 2015

What Can The Biopharmaceutical Industry Learn From Apple Inc.?

Jan 14 2014

Methodology: R&D Productivity Ranking

Dec 15 2016

Value-Based Pharma R&D Productivity: Is There A Sweet Spot?

Jun 23 2014

When It Comes To Pharma R&D ROI, Mid Pharma Companies Outperform

Oct 25 2016

Related Companies

Bausch Health Companies Inc.

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Novo Nordisk A/S

Roche Holding AG

Johnson & Johnson

Regeneron Pharmaceuticals, Inc.

Genentech, Inc.

Merck & Co., Inc.

Sanofi

AbbVie Inc.

Biogen, Inc.

Bristol Myers Squibb Company

Astellas Pharma, Inc.

Pfizer Inc.

Medivation, Inc.

Chugai Pharmaceutical Co., Ltd.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Growth BioPharmaceutical

More from Growth

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window